Compounded injectable medication recalled for lack of sterility assurance
Pharmacy Plus Inc. (Vital Care Compounder) is recalling compounded PAP/PHEN/PROSTAG/ATROPINE injections distributed in four states due to manufacturing conditions that cannot guarantee product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a sterile injectable product where manufacturing controls failed to ensure sterility. While no illnesses or injuries have been reported, the lack of sterility assurance in a sterile injectable represents a significant risk-of-harm product, meeting criteria for High severity.
Plain-English summary
Pharmacy Plus, Inc., operating as Vital Care Compounder in Hattiesburg, Mississippi, is recalling compounded PAP/PHEN/PROSTAG/ATROPINE injections in 5 mL vials. The recall affects two specific lot numbers: Lot 66369 with a beyond-use date of November 6, 2022, and Lot 66540 with a beyond-use date of November 9, 2022.
The FDA inspection revealed that these products were manufactured in a manner that cannot guarantee their sterility. Sterile injectable medications are critical drugs where sterility is essential to patient safety, as non-sterile products pose a serious risk of infection.
The recalled products were distributed to healthcare facilities in Alabama, Louisiana, Mississippi, and Tennessee. Healthcare providers who received these products should immediately identify and quarantine them and contact Pharmacy Plus for return instructions. Patients who may have received doses from the recalled lots should contact their healthcare provider.
No illnesses or injuries have been reported in connection with this recall. Anyone with questions should contact Pharmacy Plus, Inc. with the FDA recall number D-0041-2023.
The recalled product
- Product
- PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
- Manufacturer
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Category
- Drug — Compounded Injectable
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: 66369
- BUD: 11/06/2022
- 66540
- BUD: 11/09/2022
Distribution
Distributed in 4 states:
- AL
- LA
- MS
- TN
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27